Phase III randomized trial of CED of IL13-PE38QQR vs Gliadel wafers for recurrent glioblastoma.
Kunwar S; Chang S; Westphal M; Vogelbaum M; Sampson J; Barnett G; Shaffrey M; Ram Z; Piepmeier J; Prados M; Croteau D; Pedain C; Leland P; Husain SR; Joshi BH; Puri RK; Neuro-Oncology, 2010, vol. 12, issue 8, p 871, ISSN 15235866. ISBN 15235866.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef